Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junwen Deng

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|January 1, 2024
The clinical development of antibody-drug conjugates for non-small cell lung cancer therapyXinlin Liu, Junwen Deng, Renshuai Zhang, et al.
Scientific Reports|December 16, 2014
Free-standing Fe2O3 nanomembranes enabling ultra-long cycling life and high rate capability for Li-ion batteriesXianghong Liu, Wenping Si, Jun Zhang, et al.
Frontiers in Immunology|November 13, 2023
A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cellsXinlin Liu, Linli Luan, Xi Liu, et al.
Journal of the American Academy of Dermatology|February 22, 2023
The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysisVarsha Parthasarathy, Karen Cravero, Lillian Xu, et al.
Veterinary Microbiology|October 19, 2023
Long non-coding RNA LOC103222771 promotes infection of porcine reproductive and respiratory syndrome virus in Marc-145 cells by downregulating Claudin-4Xinxian Wang, Junlong Bi, Chao Yang, et al.
Pharmacology & Therapeutics|February 21, 2023
Corrigendum to "Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer" [Pharmacology & Therapeutics 239 (2022) 108296]Xinlin Liu, Junwen Deng, Yang Yuan, et al.
Drug Development Research|February 6, 2023
The research progress on the anxiolytic effect of plant-derived flavonoids by regulating neurotransmittersChao Wang, Shanbo Yang, Junwen Deng, et al.
Frontiers in Immunology|April 1, 2024
Integrated plasma metabolomic and cytokine analysis reveals a distinct immunometabolic signature in atopic dermatitisEmily Z Ma, Junwen Deng, Varsha Parthasarathy, et al.
Pharmacology & Therapeutics|October 8, 2022
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancerXinlin Liu, Junwen Deng, Yang Yuan, et al.
Journal of the American Academy of Dermatology|October 25, 2021
Validation of International Classification of Diseases Tenth Revision code for prurigo nodularisYoukyung Sophie Roh, Melika Marani, Una Choi, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|January 1, 2024
The clinical development of antibody-drug conjugates for non-small cell lung cancer therapyXinlin Liu, Junwen Deng, Renshuai Zhang, et al.
Scientific Reports|December 16, 2014
Free-standing Fe2O3 nanomembranes enabling ultra-long cycling life and high rate capability for Li-ion batteriesXianghong Liu, Wenping Si, Jun Zhang, et al.
Frontiers in Immunology|November 13, 2023
A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cellsXinlin Liu, Linli Luan, Xi Liu, et al.
Journal of the American Academy of Dermatology|February 22, 2023
The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysisVarsha Parthasarathy, Karen Cravero, Lillian Xu, et al.
Veterinary Microbiology|October 19, 2023
Long non-coding RNA LOC103222771 promotes infection of porcine reproductive and respiratory syndrome virus in Marc-145 cells by downregulating Claudin-4Xinxian Wang, Junlong Bi, Chao Yang, et al.
Pharmacology & Therapeutics|February 21, 2023
Corrigendum to "Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer" [Pharmacology & Therapeutics 239 (2022) 108296]Xinlin Liu, Junwen Deng, Yang Yuan, et al.
Drug Development Research|February 6, 2023
The research progress on the anxiolytic effect of plant-derived flavonoids by regulating neurotransmittersChao Wang, Shanbo Yang, Junwen Deng, et al.
Frontiers in Immunology|April 1, 2024
Integrated plasma metabolomic and cytokine analysis reveals a distinct immunometabolic signature in atopic dermatitisEmily Z Ma, Junwen Deng, Varsha Parthasarathy, et al.
Pharmacology & Therapeutics|October 8, 2022
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancerXinlin Liu, Junwen Deng, Yang Yuan, et al.
Journal of the American Academy of Dermatology|October 25, 2021
Validation of International Classification of Diseases Tenth Revision code for prurigo nodularisYoukyung Sophie Roh, Melika Marani, Una Choi, et al.
Pageof 7